Infex Therapeutics is Drug Discovery in United Kingdom that focus on research institutions business. Founded in 2016. They cover business area such as developer, medicinal drug, new antibiotic, antimicrobial resistance, antimicrobial drug, diagnostic, translational r&d, pre-clinical hit, clinical proof, concept, company, research institution, their product, lead optimization.
2016
( 8 years old in 2024 )
Research Institutions
-
19B70, Mereside
Alderley Park, Cheshire
Alderley Edge SK10 4TG
England, United Kingdom
Private
developermedicinal drugnew antibioticantimicrobial resistanceantimicrobial drugdiagnostictranslational r&dpre-clinical hitclinical proofconceptcompanyresearch institutiontheir productlead optimization
* We use standard office opening hours in near Infex Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Infex Therapeutics is Drug Discovery business from United Kingdom that founded in 2016 (8 years old in 2024), Infex Therapeutics business is focusing on Research Institutions.
Infex Therapeutics headquarter office and corporate office address is located in 19B70, Mereside Alderley Park, Cheshire Alderley Edge SK10 4TG England, United Kingdom.
Infex Therapeutics was founded in United Kingdom.
In 2024, Infex Therapeutics is currently focus on research institutions sector.
Above is snippet of Google Trends for "research institutions" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Infex Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
